The largest database of trusted experimental protocols

4 protocols using hdac3 sirna

1

Fgf21 and MR Promoter Cloning

Check if the same lab product or an alternative is used in the 5 most similar protocols
A 3-kb mouse Fgf21 promoter was amplified and cloned into pGL3-basic vector (Promega) to produce the 3-kb Fgf21-luciferase plasmid. Different fragments of Fgf21 promoter were cloned into pGL3-basic vector to yield various truncated Fgf21-luciferase plasmids. Similarly, a 2-kb mouse MR promoter was cloned into the pGL3-basic vector and produced the 2-kb MR-luciferase plasmid. The sequences of the primers used to amplify these promoters are listed in table S4.
HDAC3 siRNA, NCOR1 siRNA, and their respective control were purchased from Santa Cruz Biotechnology Inc. Primary hepatocytes were transfected with siRNA or control using Lipofectamine 2000 (Thermo Fisher Scientific) according to the manufacturer’s instructions.
+ Open protocol
+ Expand
2

siRNA Knockdown of HDAC3 in Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
siRNA-mediated knockdown of HDAC3 was performed as per manufacturer’s instructions. Cells (2 × 105) were seeded in each well of a six-well plate. After 18 h, cells were transfected with 80 pmol of control siRNA (Santa Cruz Biotechnology sc37007) and HDAC3 siRNA (Santa Cruz Biotechnology sc35539). Transfection was performed using siRNA transfection reagent (Santa Cruz Biotechnology sc29528) and siRNA transfection medium (Santa Cruz Biotechnology sc36868). After 24 h, the transfection medium was replaced with fresh culture medium, and the cells were further incubated for 48 h (72 h posttransfection). Cells were then used for compressive force assay.
+ Open protocol
+ Expand
3

Evaluating HDAC Inhibitor Effects

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant human TGF‐β1 (PHG9204) was purchased from Invitrogen (Waltham, MA, USA). Trichostatin A (TSA) was purchased from Sigma (T8552, St. Louis, MO, USA). MS275 and PCI34051 were purchased from Selleckchem (S1053 and S2012, respectively, Burlington, NC, USA). LMK235 was obtained from Prof. Thomas Kurz (Heinrich‐Heine Universität Düsseldorf, Germany) and synthesized according to a previously published protocol 15. To rule out the siRNA off‐target effect, we used siRNAs from two companies (Bioneer and Santa Cruz). siRNAs against HDAC1, HDAC2, and HDAC3 were purchased from Bioneer (Gyeonggi‐do, South Korea) and siRNAs against HDAC2, HDAC3, and HDAC8 were purchased from Santa Cruz Biotechnology (Dallas, TX, USA); HDAC2 siRNA (sc‐29345), HDAC3 siRNA (sc‐35538), and HDAC8 siRNA (sc‐35548).
+ Open protocol
+ Expand
4

Characterization of HIV-1 Vpr Interacting Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
HDAC1 (ab7028), HDAC2 (ab7029), HDAC3 (ab32369), HDAC8 (ab18968), histone H3 (ab70550), and HIV-1 Tat (ab43014) antibodies were purchased from Abcam. VprBP (A301-888A) antibody was from Bethyl Laboratories. Flag antibody (F3165) was from Sigma-Aldrich. GAPDH (14C10) and rabbit IgG isotype control (2729) were from Cell Signaling Technology. Anti-p24-PE (sc-69728 PE) was from Santa Cruz. Ace H3K9 (39917) and Ace H4K5 (39699) antibodies were from active motif. Mouse and rabbit HRP-conjugated antibodies were from Abcam. Monoclonal antibody against a conserved region of HIV-1 Vpr was raised in mouse by conjugating KLH (keyhole limpet hemocyanin) to a synthetic peptide (EAVRHFPRHWLHGLGQ) corresponding to amino acids 29–44 of Vpr prevalent among clinical isolates. SYBR Select Master Mix was from Life Technologies. Benzonase nuclease was from Novagen. Caffeine, Flag peptides, SAHA, and DMSO were from Sigma-Aldrich. MG132 was from Millipore. VprBP and non-targeting siRNAs were from Dharmacon. HDAC1 siRNA was from Qiagen. HDAC3 siRNA was from Santa Cruz Biotechnology. HDAC-Glo™ I/II Reagent was from Promega.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!